Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview

Published:2012-07-20 Issue:5 Volume:27 Page:633-636
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytother. Res.

Author:

Esposito Giuseppe¹,Filippis Daniele De²,Cirillo Carla³,Iuvone Teresa²,Capoccia Elena¹,Scuderi Caterina¹,Steardo Antonio¹,Cuomo Rosario³,Steardo Luca¹

Affiliation:

1. Department of Physiology and Pharmacology ‘Vittorio Erspamer’, Faculty of Pharmacy and Medicine; Sapienza University of Rome; Italy

2. Department of Experimental Pharmacology; Faculty of Pharmacy; Naples Italy

3. Department of Clinical and Experimental Medicine; University Federico II of Naples; Naples Italy

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ptr.4781/fullpdf

Reference50 articles.

1. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability;Alhamoruni;J Pharmacol Exp Ther,2010

2. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability;Alhamoruni;Br J Pharmacol,2012

3. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer;Aviello;J Mol Med

4. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis;Borrelli;J Mol Med,2009

5. Cannabinoids, endocannabinoids, and related analogs in inflammation;Burstein;AAPS J,2009

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro;Toxicology in Vitro;2024-08

2. Cannabidiol decreases histological intestinal injury in a neonatal experimental model of necrotizing enterocolitis;Laboratory Animal Research;2024-06-27

3. Cannabidiol (CBD): Confronting consumers’ expectations of therapeutic benefits with pharmacological reality;Therapies;2024-02

4. The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD;Inflammation Research;2024-01-08

5. Long COVID-19 and the potential use of palmitoylethanolamide;Linking Neuroscience and Behavior in COVID-19;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3